2017

1. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

   Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202